Method and kit for identifying and/or quantifying radiolabeled aminoglycoside binding molecules
View Patent ↗The present invention describes novel methods, assays and kits for identifying and/or quantifying Aminoglycoside Binding Molecules (ABMs), enzymes modifying such molecules, and compounds modulating the interaction between ABMs and either enzymes or aminoglycosides, by exploiting the scintillation proximity effect. The invention, which makes use of aminoglycoside-coated scintillating supports, can be adapted to high throughput screening formats.
1. A method for identifying and/or quantifying radiolabeled Aminoglycoside Binding Molecules (ABMs) in a sample, said method comprising the following steps:
a) preparing a sample comprising at least an ABM and an enzyme;
b) allowing said enzyme either to add a radiolabeled group present in the sample to the ABM, or to cleave a radiolabeled group present in the ABM;
c) incubating the sample with one or more solid supports impregnated with a scintillant compound and covered with an aminoglycoside; and
d) measuring the level of emission generated by the one or more scintillating supports; and
e) correlating said level of emission to the presence or amount of said radiolabeled Aminoglycoside Binding Molecules to identify and/or quantify radiolabeled ABM's.
2. The method of claim 1 wherein the sample and the one or more support (s) are separated between steps (c) and (d).
3. The method of claim 1 wherein different samples prepared according to step (a) comprise equal amount of the ABM, equal amount of the enzyme that either adds a radiolabeled group present in the sample to the ABM or cleaves a radiolabeled group present in the ABM, and wherein said different samples are prepared with or without one or more candidate inhibitors of the enzyme or of the interaction between the ABM and the aminoglycoside which are added before or during step (c).
4. An assay for identifying and/or quantifying compounds which modulate an interaction between an ABM and an enzyme that adds a radiolabeled group present in the sample to the ABM or cleaves a radiolabeled group present in the ABM, wherein the radiolabeled ABM is identified and/or quantified according to the method of claim 3 .
5. The assay of claim 4 wherein the compounds are potential inhibitors of the enzyme.
6. The assay of claim 4 , wherein the compounds are aminoglycoside-modifying bacterial enzymes.
7. The assay of claim 4 wherein the one or more supports are beads.
8. The assay of claim 4 wherein the aminoglycoside is neomycin.
9. The assay of claim 4 wherein the ABM is a mono- or polyphosphatated phosphoinositide.
10. The assay of claim 9 wherein the enzyme is a phosphoinositide kinase.
11. The assay of claim 4 wherein the ABM is an RNA molecule.
12. An assay for identifying and/or quantifying compounds which modulate an interaction between an ABM and an aminoglycoside, said assay comprising quantifying radiolabeled ABM according to the method of claim 3 .
13. The method of claim 1 wherein different samples prepared according to step (a) comprise equal amount of the ABM, equal amount of the enzyme that either adds a radiolabeled group present in the sample to the ABM or cleaves a radiolabeled group present in the ABM, with or without one or more candidate inhibitors of the enzyme or of the interaction between the ABM and the aminoglycoside added before or during step (c).
14. The method of claim 1 wherein different samples prepared according to step (a) comprise equal amount of the ABM, and different mixtures of molecules potentially containing an enzyme that either adds a radiolabeled group present in the sample to the ABM or cleaves a radiolabeled group present in the ABM.
15. The method of claim 1 wherein different samples prepared according to step (a) comprise equal amount of an enzyme that either adds a radiolabeled group present in the sample to the ABM or cleaves a radiolabeled group present in the ABM, and different mixtures of molecules potentially containing an ABM.
16. An assay for identifying and/or quantifying an enzyme that either adds a radiolabeled group present in the sample to the ABM or cleaves a radiolabeled group present in the ABM, wherein the radiolabeled ABM is identified and/or quantified according to the method of claim 1 .
17. An assay for identifying and/or quantifying an ABM, said assay comprising quantifying radiolabeled ABM according to the method of claim 1 .
18. A kit for identifying and/or quantifying aminoglycoside binding molecules, enzymes modifying said molecules, or compounds modulating the interaction between ABMs and either enzymes or aminoglycosides, comprising a scintillating solid support covered with an aminoglycoside.